中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
  4. 新药研究国家重点实验室
Design and synthesis of selective degraders of EGFR(L858R/T790M) mutant

文献类型：期刊论文

作者Zhang, Xin1; Xu, Fang1; Tong, Linjiang2; Zhang, Tao2; Xie, Hua2; Lu, Xiaoyun1; Ren, Xiaomei1; Ding, Ke1
刊名EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
出版日期2020-04-15
卷号192页码:14
ISSN号0223-5234
关键词Epidermal growth factor receptor (EGFR) Resistance Proteolysis targeting chimera (PROTAC) Protein degradation
DOI10.1016/j.ejmech.2020.112199
通讯作者Ren, Xiaomei(ren_xiaomei@jnu.edu.cn) ; Ding, Ke(dingke@jnu.edu.cn)
英文摘要A series of PROTAC (proteolysis targeting chimera) based selective EGFR(L858R/T790M) (leucine 858 to arginine 858 mutation and threonine 790 to methionine 790) mutant degraders were designed and synthesized. One of the most potent compounds, 14o, effectively and selectively degraded EGFR(L858R/T790M) with an DC50 value of 5.9 nM, while did not show obvious effect on the wild-type protein. Further mechanism investigation revealed that the degradation was mediated by ubiquitin proteasome pathway. Compound 14o could be utilized as an initial lead molecule for development of new EGFR(L858R/T790M) degrader based therapy. (c) 2020 Elsevier Masson SAS. All rights reserved.
WOS关键词INDUCED PROTEIN-DEGRADATION ; CELL LUNG-CANCER ; EGFR ; INHIBITOR ; RESISTANCE ; DISCOVERY ; AZD9291 ; MUTATIONS ; DERIVATIVES
资助项目National Natural Science Foundation of China[21807044] ; National Natural Science Foundation of China[21572230] ; National Natural Science Foundation of China[81425021] ; National Natural Science Foundation of China[81673285] ; National Natural Science Foundation of China[81820108029] ; Guangdong Province[1814050000441] ; Guangdong Province[2014TQ01R341] ; Guangdong Province[2015A030306042] ; Guangdong Province[2015A030312014] ; Guangdong Province[2016A050502041] ; Guangzhou city[201805010007]
WOS研究方向Pharmacology & Pharmacy
语种英语
出版者ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
WOS记录号WOS:000523563100004
源URL[http://119.78.100.183/handle/2S10ELR8/280825]  
专题新药研究国家重点实验室
通讯作者Ren, Xiaomei; Ding, Ke
作者单位1.Jinan Univ, Int Cooperat Lab Tradit Chinese Med Modernizat &, Guangzhou City Key Lab Precis Chem Drug Dev, Sch Pharm,Minist Educ MOE China, 601 Huangpu Ave West, Guangzhou 510632, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714		 Zhang, Xin,Xu, Fang,Tong, Linjiang,et al. Design and synthesis of selective degraders of EGFR(L858R/T790M) mutant[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2020,192:14.
APA Zhang, Xin.,Xu, Fang.,Tong, Linjiang.,Zhang, Tao.,Xie, Hua.,...&Ding, Ke.(2020).Design and synthesis of selective degraders of EGFR(L858R/T790M) mutant.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,192,14.
MLA Zhang, Xin,et al."Design and synthesis of selective degraders of EGFR(L858R/T790M) mutant".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 192(2020):14.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。